Tags

Type your tag names separated by a space and hit enter

Comparison of schizophrenia drugs often favors firm funding study.
Washington Post 2006; :A1, A6WP

Authors

No affiliation info available

Pub Type(s)

Comparative Study
Newspaper Article

Language

eng

PubMed ID

16856276

Citation

Vendantam, Shankar. "Comparison of Schizophrenia Drugs Often Favors Firm Funding Study." The Washington Post, 2006, pp. A1, A6.
Vendantam S. Comparison of schizophrenia drugs often favors firm funding study. Washington Post. 2006.
Vendantam, S. (2006). Comparison of schizophrenia drugs often favors firm funding study. The Washington Post, pp. A1, A6.
Vendantam S. Comparison of Schizophrenia Drugs Often Favors Firm Funding Study. Washington Post. 2006 Apr 12;A1, A6. PubMed PMID: 16856276.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Comparison of schizophrenia drugs often favors firm funding study. A1 - Vendantam,Shankar, PY - 2006/7/22/pubmed PY - 2006/8/24/medline PY - 2006/7/22/entrez KW - Biomedical and Behavioral Research KW - Empirical Approach KW - Mental Health Therapies KW - Popular Approach/Source SP - A1, A6 JF - The Washington post JO - Washington Post UR - https://www.unboundmedicine.com/medline/citation/16856276/Comparison_of_schizophrenia_drugs_often_favors_firm_funding_study_ L2 - http://www.diseaseinfosearch.org/result/6442 DB - PRIME DP - Unbound Medicine ER -